Treatment of dysthymic disorder

Depression and Anxiety

Volumn 8, Issue SUPPL. 1, 1998, Pages 54-58

  Dunner, David L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Outpatient Psychiatry Center   (United States)

Author keywords

Dysthmic disorder; Fluoxetine; Psychopharmacology

Indexed keywords

FLUOXETINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANOREXIA; ARTICLE; CLINICAL FEATURE; COGNITIVE THERAPY; DEPRESSION; DYSTHYMIA; FATIGUE; HUMAN; INSOMNIA; MANIA; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; SELF ESTEEM;

DYSTHYMIC DISORDER; FLUOXETINE; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031788535     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:1+<54::AID-DA8>3.0.CO;2-5     Document Type: Article

References (39)

1. Akiskal HS (1981) Subaffective disorders: Dysthymia, cyclothymia, and bipolar II disorders in the "borderline" realm. Psychiatr Clin North Am 4:25-46.
2. Akiskal HS, Rosenthal TL, Haykal RF, Lewis H, Rosenthal RH, Scott-Strauss A (1980) Characteriological depressions: Clinical and sleep EEG findings separating "subaffective dysthymias" from "character spectrum disorders." Arch Gen Psychiatry 33:777-783.
3. APA (1980) Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association.
4. APA (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association.
5. Beck AT (1978) Beck Depression Inventory (BDI), 1978. Philadelphia: Center for Cognitive Therapy.
6. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974) The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 19:1-15.
7. Dunner DL (1996) Efficacy of selective serotonin reuptake inhibitors in the treatment of dysthymia. In Feighner JP, Boyer WF (eds): Selective Serotonin Re-uptake Inhibitors: Advances in Basic Research and Clinical Practice. Chichester: John Wiley & Sons, pp 223-232.
8. Dunner DL, Schmaling KB, Hendrickson H, Becker J, Lehman A, Bea C (1996) Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression 4:34-41.
9. Dunner DL, Hendrickson HE, Bea CJ, Budech CB (1997) Treatment of dysthymic disorder with venlafaxme. Presented at the 52nd annual meeting, Society of Biological Psychiatry, May 14-18, 1997. Biol Psychiatry 44:925.
10. Elkin I, Shea TM, Watkins JT, Imber SD, Sotsky SM, Collms JS, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parioff MB (1989) The National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Arch Gen Psychiatry 46:971-982.
11. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991) Conceptualization and rationale of consensus definitions of terms in major depression and depressive disorder - remission, recovery, relapse and recurrence. Arch Gen Psychiatry 48:851-855.
12. Goldberg JF, Kocsis JH (1997) Diagnosis and treatment of dysthymic disorder: New findings. In Dunner DL (ed): Current Psychiatric Therapy II. Philadelphia: W.B. Saunders, pp 232-238.
13. Goodman DW, Goldstein RB, Adams PB, Horwath E, Sobin C, Wickramaratne P, Weissman MM (1994/5) Relationship between dysthymia and major depression: An analysis of family study data. Depression 2:252-258.
14. Guy W (ed) (1976) ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, MD: US Department of Health, Education and Welfare.
15. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
16. Han L, Schmaling KB, Dunner DL (1995) Descriptive validity and stability of diagnostic criteria for dysthymic disorder. Comp Psychiatry 36:338-343.
17. Harrison WM, Stewart JW (1993) Pharmacotherapy of dysthymia. Psychiatric Ann 23:638-648.
18. Hellerstein DJ, Yanowich P, Rosenthal J, Samstag LW, Maurer M, Kasch K, Burrows L, Poster M, Cantillon M, Winston A (1993) A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 150:1169-1175.
19. Howland RH (1991) Pharmacotherapy of dysthymia. A review. J Clin Psychopharmacol 11:83-92.
20. Keller MB, Shapiro RW (1982) Double depression. Superimpostion of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 139:438-442.
21. Keller MB, Baker LA, Russell CW (1993) Classification and treatment of dysthymia. In Dunner DL (ed): Current Psychiatry Therapy. Philadelphia: W.B. Saunders, pp 210-224.
22. Keller MB, Klein DN, Hirschfeld RMA, Kocsis JH, McCullough JP, Miller I, First MB, Holzer CP III, Keitner GI, Marin DB, Shea T (1995) Results of the DSM-IV mood disorders field trial. Am J Psychiatry 152:843-849.
23. Klein DN, Riso LP, Donaldson SK, Schwartz JE, Anderson RL, Ouimette PC, Lizardi H, Aronson T (1995) Family study of early onset dysthymia. Arch Gen Psychiatry 52:487-496.
24. Kocsis JH, Frances AJ (1987) A critical discussion of DSM-III dysthymic disorder. Am J Psychiatry 144:1534-1542.
25. Kovacs M, Akiskal HS, Gatsonis C, Parrone P (1994) Childhood-onset dysthymic disorder. Arch Gen Psychiatry 51:365-374.
26. Markowitz JC (1996) Psychotherapy for dysthymic disorder. Psychiatr Clin North Am 19:133-149.
27. Mason BJ, Kocsis JH, Leon AC, Thompson S, Frances AJ, Morgan RO, Parides MK (1993) Measurement of severity and treatment response in dysthymia. Psychiatr Ann 23:625-631.
28. McCullough JP (1991) Psychotherapy for dysthymia. J Nerv Ment Dis 179:734-740.
29. Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D (1994) Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates. Int Clin Psychopharmacol 9:47-53.
30. Nobler MS, Devanand DP, Kim MK, Fitzisimons LM, Singer TM, Jurret N, Sackheim HA, Roose SP (1996) Fluoxetine treatment of dysthymia in the elderly. J Clin Psychiatry 57:254-256.
31. Pages KP, Dunner DL (1997) Focus on dysthymic disorder and chronic depression. In Dunner DL, Rosenbaum JH (eds): The Psychiatric Clinics of North America Annual of Drug Therapy 1997. Philadelphia: W.B. Saunders, pp 91-109.
32. Ravindran AV, Bialik RJ, Lapierre YD (1994) Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia. Can J Psychiatry 39:21-26.
33. Rosenthal J, Hemlock C, Hellerstein DJ, Yanowich P, Kasch K, Schupak C, Samstag, Winston A (1992): A preliminary study of serotonergic antidepressants in treatment of dysthymia. Prog Neuropsychpharmacol Biol Psychiatry 16:933-941.
34. Sclar DA, Robison LM, Skaer TL, Legg RF, Nemec NL, Galin RS, Hughes TE, Bueschjng DP (1994) Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization. Clin Ther 16:715-730.
35. Shea MT, Widiger T, Klein MH (1992) Comorbidity of personality disorders and depression: Implications for treatment. J Consult Clin Psychol 60.857-868.
36. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W (1997) A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53: 777-784.
37. Vanelle JM, Attar-Levy D, Poirer MF, Bouhassira M, Blin P, Olie JP (1997) Controlled efficacy study of fluoxetine in dysthymia. Br J Psychiatry 170:345-350.
38. Weissman MM, Leaf PJ, Brace ML, Florio L (1988) The epidemiology of dysthymia in five communities: Rates, risks, comorbidity and treatment. Am J Psychiatry 145:815-819.
39. WHO (World Health Organization) (1992) The ICD-10 classification of mental and behavioral disorders - clinical descriptions and diagnostic guideline. WHO, Geneva.